Milind N Naik Selected Research

Milind N Naik Research Topics

Disease

7	Infections 04/2024 - 07/2015
6	Endophthalmitis (Ophthalmia) 11/2022 - 01/2021
6	Cysts 03/2019 - 05/2005
5	Dacryocystitis (Dacryoadenitis) 08/2019 - 03/2015
5	Neoplasms (Cancer) 05/2018 - 07/2005
4	Inflammation (Inflammations) 08/2019 - 05/2010
4	Lacrimal Duct Obstruction 07/2016 - 07/2012
3	Graves Ophthalmopathy 01/2021 - 09/2008
3	Lacrimal Apparatus Diseases (Epiphora) 05/2017 - 01/2013
3	Abscess 03/2016 - 07/2013
2	Granuloma 04/2024 - 05/2017
2	Blepharoptosis (Ptosis, Eyelid) 04/2024 - 03/2018
2	Entropion 12/2023 - 06/2022
2	Orbital Cellulitis 12/2022 - 06/2014
2	Disease Progression 01/2022 - 01/2021
2	Ectropion 01/2020 - 01/2010
2	Lagophthalmos 01/2020 - 06/2007
2	Cicatrix (Scar) 11/2016 - 09/2016
2	Bacteremia 03/2016 - 01/2014
2	Carcinoma (Carcinomatosis) 01/2016 - 07/2005
2	Edema (Dropsy) 03/2015 - 03/2015
2	Lacerations 02/2008 - 01/2008
2	Microphthalmos 07/2007 - 05/2005
1	Suppuration 12/2022
1	Mucormycosis 04/2022
1	Retinal Detachment (Retinal Detachments) 03/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2022
1	Glaucoma 01/2021
1	Ichthyosis (Xeroderma) 01/2020
1	Cataract (Cataracts) 01/2020
1	Hoarseness 12/2019
1	Benign essential blepharospasm 10/2019
1	Fibrosis (Cirrhosis) 08/2019
1	monocular elevation deficiency 05/2019
1	Papilloma (Papillomatosis) 06/2018
1	Residual Neoplasm 05/2018
1	Pathologic Constriction (Stenosis) 01/2018
1	Calcinosis Cutis 01/2018
1	Dry Eye Syndromes (Dry Eye Syndrome) 06/2017
1	Vascular Malformations 09/2016

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 09/2012
4	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2022
4	Retinaldehyde (Retinal)IBA 01/2022 - 09/2012
3	Biomarkers (Surrogate Marker)IBA 11/2022 - 09/2022
3	SteroidsIBA 08/2019 - 06/2014
2	ProteomeIBA 11/2022 - 10/2022
2	SiliconesIBA 05/2019 - 01/2014
2	Sodium Tetradecyl Sulfate (Sotradecol)FDA Link 03/2019 - 05/2014
2	Fluorouracil (Carac)FDA LinkGeneric 12/2015 - 07/2005
2	PlasticsIBA 03/2015 - 07/2013
2	Coloring Agents (Dyes)IBA 01/2014 - 01/2013
2	ethanolamine oleate (Ethamolin)FDA Link 07/2007 - 05/2005
1	SuspensionsIBA 04/2024
1	EthibondIBA 04/2024
1	PolyestersIBA 04/2024
1	FluoroquinolonesIBA 12/2022
1	Annexin A5IBA 11/2022
1	Cathepsin DIBA 11/2022
1	Caveolin 1IBA 10/2022
1	TenascinIBA 10/2022
1	Caveolin 2IBA 10/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	InterleukinsIBA 01/2022
1	LigandsIBA 01/2022
1	Methicillin (Metin)FDA Link 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Macrophage Colony-Stimulating FactorIBA 01/2022
1	Interferon Receptors (Interferon Receptor)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	UbiquitinIBA 01/2022
1	Immunomodulating AgentsIBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Periodic AcidIBA 12/2019
1	Type A Botulinum Toxins (Botox)FDA Link 10/2019
1	Phenobarbital (Luminal)FDA Link 08/2019
1	Sclerosing Solutions (Sclerosing Agents)IBA 03/2019
1	InterferonsIBA 06/2018
1	Interferon-alpha (Interferon Alfa)IBA 06/2018
1	CalciumIBA 01/2018
1	SaltsIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 12/2015

Therapy/Procedure

10	Dacryocystorhinostomy 08/2019 - 07/2012
5	Sclerotherapy 03/2019 - 05/2005
5	Stents 01/2018 - 01/2008
3	Decompression 12/2023 - 01/2021
3	Drug Therapy (Chemotherapy) 05/2018 - 12/2015
3	Neoadjuvant Therapy 01/2016 - 07/2005
3	Therapeutics 09/2012 - 09/2008
2	Curettage 05/2018 - 09/2012
1	Reoperation 04/2024
1	Sutures (Suture) 04/2024
1	General Anesthesia 04/2022
1	Local Anesthesia 04/2022
1	Vitrectomy 03/2022
1	Endoscopes 03/2018
1	Radiotherapy 06/2017
1	Trephining 11/2016
1	Cautery 09/2016
1	Antibiotic Prophylaxis 03/2016